The influence of glutamatergic antagonism on motor variability, and comparison to findings in schizophrenia patients

Acta Neuropsychiatrica

Volumn 25, Issue 2, 2013, Pages 105-112

  Johnsen, Erik ^a,b   Fasmer, Ole Bernt ^a,b   Van Wageningen, Heidi ^b   Hugdahl, Kenneth ^a,b   Hauge, Erik ^c   Jorgensen, Hugo A ^b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Olaviken Psychiatric Hospital   (Norway)

Author keywords

glutamate antagonists; motor activity; schizophrenia

Indexed keywords

CHLORPROMAZINE; CLOZAPINE; EBIXIA; GLUTAMATE RECEPTOR ANTAGONIST; MEMANTINE; NEUROLEPTIC AGENT; UNCLASSIFIED DRUG;

ACTIMETRY; ADULT; ARM; ARTICLE; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIZZINESS; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; ENTROPY; FEMALE; HUMAN; HYPERTENSION; MALE; MENTAL PATIENT; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NAUSEA; PATIENT MONITORING; REGRESSION ANALYSIS; ROOT MEAN SQUARE SUCCESSIVE DIFFERENCE; SCHIZOPHRENIA; SOMNOLENCE; STEADY STATE; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84880316856     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2012.00674.x     Document Type: Article

References (32)

1. Tzschentke TM. Glutamatergic mechanisms in different disease states: Overview and therapeutical implications -An introduction. Amino Acids 2002;23:147-152
2. Kalia LV, Kalia SK, Salter MW. NMDA receptors in clinical neurology: Excitatory times ahead. Lancet Neurol 2008;7:742-755 (Pubitemid 351957932)
3. Sukhanov IM, Zakharova ES, Danysz W, Bespalov AY. Effects of NMDA receptor channel blockers, MK-801 and memantine, on locomotor activity and tolerance to delay of reward in Wistar-Kyoto and spontaneously hypertensive rats. Behav Pharmacol 2004;15:263-271 (Pubitemid 39062555)
4. Mares P, Mikulecka A. Different effects of two N-methyl-D-Aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats. Epilepsy Behav 2009;14:32-39
5. Andreassen OA, Aamo TO, Joorgensen HA. Inhibition by memantine of the development of persistent oral dyskinesias induced by long-Term haloperidol treatment of rats. Br J Pharmacol 1996;119:751-757 (Pubitemid 26356589)
6. Andreassen OA, Waage J, Finsen B, Jorgensen HA. Memantine attenuates the increase in striatal preproenkephalin mRNA expression and development of haloperidol-induced persistent oral dyskinesias in rats. Brain Res 2003;994:188-192 (Pubitemid 37464882)
7. Schwenkreis P, Witscher K, Pleger B, Malin JP, Tegenthoff M. The NMDA antagonist memantine affects training induced motor cortex plasticity-A study using transcranial magnetic stimulation. BMC Neurosci 2005;6:35
8. Rammsayer TH. NMDA receptor activity and the transmission of sensory input into motor output in introverts and extraverts. Q J Exp Psychol B 2003;56:207-221 (Pubitemid 37353296)
9. Morrens M, Hulstijn W, Sabbe B. Psychomotor slowing in schizophrenia. Schizophr Bull 2007;33:1038-1053 (Pubitemid 47216642)
10. Pappa S, Dazzan P. Spontaneous movement disorders in antipsychotic-Naive patients with first-episode psychoses: A systematic review. Psychol Med 2009;39:1065-1076
11. Berle JO, Hauge ER, Oedegaard KJ, Holsten F, Fasmer OB. Actigraphic registration of motor activity reveals a more structured behavioural pattern in schizophrenia than in major depression. BMC Res Notes 2010;3:149
12. Di Mascio M, Di Giovanni G, Di Matteo V, Esposito E. Decreased chaos of midbrain dopaminergic neurons after serotonin denervation. Neuroscience 1999;92:237-243 (Pubitemid 29249034)
13. Ehlers CL. Chaos and complexity. Can it help us to understand mood and behavior? Arch Gen Psychiatry 1995;52:960-964
14. Huikuri HV, Makikallio TH, Peng CK, Goldberger AL, Hintze U, Moller M. Fractal correlation properties of R-R interval dynamics and mortality in patients with depressed left ventricular function after an acute myocardial infarction. Circulation 2000;101:47-53 (Pubitemid 30039075)
15. Ilias I, Vgontzas AN, Provata A, Mastorakos G. Complexity and non-Linear description of diurnal cortisol and growth hormone secretory patterns before and after sleep deprivation. Endocr Regul 2002;36:63-72
16. Kramlinger KG, Post RM. Ultra-rapid and ultradian cycling in bipolar affective illness. Br J Psychiatry 1996;168:314-323
17. Liu PY, Iranmanesh A, Keenan DM, Pincus SM, Veldhuis JD. A noninvasive measure of negative-feedback strength, approximate entropy, unmasks strong diurnal variations in the regularity of LH secretion. Am J Physiol Endocrinol Metab 2007;293:E1409-E1415 (Pubitemid 350106611)
18. Tuzcu V, Nas S, Borklu T, Ugur A. Decrease in the heart rate complexity prior to the onset of atrial fibrillation. Europace 2006;8:398-402 (Pubitemid 43905712)
19. Aboy M, Cuesta-Frau D, Austin D, Mico-Tormos P. Characterization of sample entropy in the context of biomedical signal analysis. Conf Proc IEEE Eng Med Biol Soc 2007;2007:5943-5946
20. Hauge ER, Berle JO, Oedegaard KJ, Holsten F, Fasmer OB. Nonlinear analysis of motor activity shows differences between schizophrenia and depression: A study using Fourier analysis and sample entropy. PLoS One 2011;6:e16291
21. Rhoades HM, Overall JE. The semistructured BPRS interview and rating guide. Psychopharmacol Bull 1988;24:101-104
22. Nose M, Tansella M, Thornicroft G, et al. Is the Defined Daily Dose system a reliable tool for standardizing antipsychotic dosages? Int Clin Psychopharmacol 2008;23:287-290
23. Parsons CG, Danysz W, Quack G. Memantine is a clinically well tolerated N-methyl-D-Aspartate (NMDA) receptor antagonist-A review of preclinical data. Neuropharmacology 1999;38:735-767 (Pubitemid 29187336)
24. Richman JS, Moorman Jr. Physiological time-series analysis using approximate entropy and sample entropy. Am J Physiol Heart Circ Physiol 2000;278:H2039-H2049 (Pubitemid 30439218)
25. Goldberger AL, Amaral LA, Glass L, et al. PhysioBank, PhysioToolkit, and PhysioNet: Components of a new research resource for complex physiologic signals. Circulation 2000;101:E215-E220
26. Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin's error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull 2010;36:314-320
27. Tandon R, Jibson MD. Extrapyramidal side effects of antipsychotic treatment: Scope of problem and impact on outcome. Ann Clin Psychiatry 2002;14:123-129 (Pubitemid 35006794)
28. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: Version III-The final common pathway. Schizophr Bull 2009;35:549-562
29. Korchounov A, Meyer MF, Krasnianski M. Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation. J Neural Transm 2010;117:1359-1369
30. Abi-Dargham A, Laruelle M. Mechanisms of action of second generation antipsychotic drugs in schizophrenia: Insights from brain imaging studies. Eur Psychiatry 2005;20:15-27 (Pubitemid 40092387)
31. Leucht S, Corves C, Arbter D, Engel RR, Li C, Davis JM. Second-generation versus first-generation antipsychotic drugs for schizophrenia: A meta-Analysis. Lancet 2009;373:31-41
32. Walther S, Horn H, Razavi N, Koschorke P, Muller TJ, Strik W. Quantitative motor activity differentiates schizophrenia subtypes. Neuropsychobiology 2009; 60:80-86